Phacilitate Leaders World

Conference speakers

Loading
Robert S. Jones

Robert S. Jones

Vice President, Global Bioservices, Cryoport

Cryoport is the industry’s most trusted provider of cold chain logistics solutions for temperature-sensitive life sciences materials, serving advanced therapy, reproductive medicine and animal health organizations around the world.

His background was initially in Haematology and Blood Transfusion Medicine and qualified as a Fellow of the Institute of Biomedical Scientists (FIBMS) in 1986. He worked for the UK National Blood Service at their Birmingham laboratories for 10 years before moving into a commercial role with DuPont, and finally Thermo Fisher Scientific.

In 2004 he set up the Fisher Bioservices UK facility in Bishops Stortford and directed the business as General Manager, supporting over 100 advanced therapy clinical trials from Phase I to Phase III

His main areas of interest are in supply chain management of advanced therapies, cryogenic storage and packaging, and the development of innovation and technology in ultra low temperature and cryogenic workflows.

He is also a Member of the Royal Society of Biology and Member of the Institute of Clinical Research.

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK